[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Bionavgator KB KB posts on X about acquisition, $cytk, sanofi, $rvmd the most. They currently have XXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::136661488/interactions)  - X Week XXXXXX +7,026% - X Month XXXXXX +60% - X Months XXXXXXX +6,129% - X Year XXXXXXX +17,639% ### Mentions: XX [#](/creator/twitter::136661488/posts_active)  - X Months XX +857% - X Year XX +2,367% ### Followers: XXX [#](/creator/twitter::136661488/followers)  - X Week XXX +16% - X Month XXX +25% - X Months XXX +186% - X Year XXX +91% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::136661488/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) XX% [stocks](/list/stocks) XX% [currencies](/list/currencies) XXXX% **Social topic influence** [acquisition](/topic/acquisition) #235, [$cytk](/topic/$cytk) #5, [sanofi](/topic/sanofi) #8, [$rvmd](/topic/$rvmd) #5, [$abvx](/topic/$abvx) #2, [$bbio](/topic/$bbio) #6, [$mdgl](/topic/$mdgl) #5, [at least](/topic/at-least) 12.5%, [$asnd](/topic/$asnd) #3, [$tern](/topic/$tern) XXXX% **Top accounts mentioned or mentioned by** [@seedy19tron](/creator/undefined) [@aggregategains](/creator/undefined) [@aaronrosenblum5](/creator/undefined) [@doepkemichel](/creator/undefined) [@bananaoncology](/creator/undefined) [@banana_oncology](/creator/undefined) [@40](/creator/undefined) [@doodaddoctor](/creator/undefined) [@dwights2025](/creator/undefined) [@jbsteelers36](/creator/undefined) [@houndcl](/creator/undefined) [@bigchodu](/creator/undefined) [@curioso_et_cie](/creator/undefined) [@randombiothinks](/creator/undefined) [@craigster771](/creator/undefined) [@streetcred2017](/creator/undefined) [@maximizebelief2](/creator/undefined) [@psaibuhr](/creator/undefined) **Top assets mentioned** [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Sanofi (SNY)](/topic/sanofi) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [Vir Biotechnology, Inc. Common Stock (VIR)](/topic/$vir) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Johnson & Johnson (JNJ)](/topic/$jnj) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) ### Top Social Posts Top posts by engagements in the last XX hours "@seedy19tron Honestly $tern has lots to prove to establish its profile if it beats scemblix from efficacy stand point with clean tox then We can assume blue sky scenarios with 5B revs not there yet. price has to cool down a bit. IMO" [X Link](https://x.com/Bionavgator/status/1997105712619540814) 2025-12-06T00:48Z XXX followers, XXX engagements "My prediction before JPM26: At least one more 15B acquisition $cytk - Sanofi $abvx - lilly $RVMD - Merck/Roche $BBIO -AZN $MDGL - NVO" [X Link](https://x.com/Bionavgator/status/1996302844731736277) 2025-12-03T19:37Z XXX followers, 19.6K engagements "@seedy19tron Sanofi csl gsk azn and may be jnj use your imagination" [X Link](https://x.com/Bionavgator/status/1997084786658267276) 2025-12-05T23:24Z XXX followers, 1664 engagements "@seedy19tron @AaronRosenblum5 Also $asnd is still cheap no competition is insight for yorvi multiple products with high rev growth could have been another insm but in wrong hands (management sucks)" [X Link](https://x.com/Bionavgator/status/1997107607576703438) 2025-12-06T00:55Z XXX followers, XXX engagements "Sold this for a loss. would look to re-enter later" [X Link](https://x.com/Bionavgator/status/1996239392642335091) 2025-12-03T15:25Z XXX followers, XXX engagements "@doepke_michel this could fit $cytk narrative too" [X Link](https://x.com/Bionavgator/status/1996298369321345455) 2025-12-03T19:19Z XXX followers, XXX engagements "@aggregategains @doepke_michel why does it have to be a french comp" [X Link](https://x.com/Bionavgator/status/1996307743775285495) 2025-12-03T19:57Z XXX followers, XX engagements "Contrarian trade idea: $janx XX puts are still cheap if the durability data disappoints stock would trade down by a lot these put could fly 3x-5x. There are lots of expectations going into XXX data ran almost XX% on the pre-data PR. If data is positive- you can buy $VIR stock after hours to minimize losses. NFA" [X Link](https://x.com/Bionavgator/status/1995540974001684796) 2025-12-01T17:10Z XXX followers, 4745 engagements "Now that Evercore confirmed more 15B deals coming some more tickers for buyout predication $arwr - Gilead $asnd - Amgen" [X Link](https://x.com/Bionavgator/status/1996668087593325036) 2025-12-04T19:49Z XXX followers, 8129 engagements "@Banana_Oncology Three names comes to mind Mrk - to fill in keytruda loe Roche- firepower to afford commercial giant in cancer therapies Azn - some synergies with ras ambition to become next decade onc power house Or may be a joint venture style acquisition.(long shot to mitigate risk)" [X Link](https://x.com/Bionavgator/status/1997171501292818892) 2025-12-06T05:09Z XXX followers, XXX engagements "@Banana_Oncology Cant or a stretch to afford Not sure bod will signoff or will be confident to make such large acquisitions given not so great ROI from high profile acqs.25B is 1/4 th of the market cap.too much risk for them" [X Link](https://x.com/Bionavgator/status/1997175015276794162) 2025-12-06T05:23Z XXX followers, XXX engagements "@seedy19tron @AaronRosenblum5 $rvmd is still affordable until it isn't soon" [X Link](https://x.com/Bionavgator/status/1997103579274805525) 2025-12-06T00:39Z XXX followers, XXX engagements "If $abvx gets acquired soon then abbv will be more aggressively looking for combo therapies to protect their empire. $pali would be a good choice as it is gut restricted with no addt'l tox even $jnj needs this strategy even with or without $ptgx acquisition. they both need a small molecule (non-biologic) to combine. $pali is in a good spot either way" [X Link](https://x.com/Bionavgator/status/1997490777488777574) 2025-12-07T02:18Z XXX followers, 4621 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Bionavgator KB
KB posts on X about acquisition, $cytk, sanofi, $rvmd the most. They currently have XXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX +7,026%
- X Month XXXXXX +60%
- X Months XXXXXXX +6,129%
- X Year XXXXXXX +17,639%
Mentions: XX #
- X Months XX +857%
- X Year XX +2,367%
Followers: XXX #
- X Week XXX +16%
- X Month XXX +25%
- X Months XXX +186%
- X Year XXX +91%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence finance XX% stocks XX% currencies XXXX%
Social topic influence acquisition #235, $cytk #5, sanofi #8, $rvmd #5, $abvx #2, $bbio #6, $mdgl #5, at least 12.5%, $asnd #3, $tern XXXX%
Top accounts mentioned or mentioned by @seedy19tron @aggregategains @aaronrosenblum5 @doepkemichel @bananaoncology @banana_oncology @40 @doodaddoctor @dwights2025 @jbsteelers36 @houndcl @bigchodu @curioso_et_cie @randombiothinks @craigster771 @streetcred2017 @maximizebelief2 @psaibuhr
Top assets mentioned Cytokinetics Inc. (CYTK) Sanofi (SNY) Revolution Medicines, Inc. Common Stock (RVMD) BridgeBio Pharma, Inc. Common Stock (BBIO) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Janux Therapeutics, Inc. Common Stock (JANX) Vir Biotechnology, Inc. Common Stock (VIR) Arrowhead Research Corporation (ARWR) Johnson & Johnson (JNJ) Protagonist Therapeutics, Inc (PTGX)
Top Social Posts
Top posts by engagements in the last XX hours
"@seedy19tron Honestly $tern has lots to prove to establish its profile if it beats scemblix from efficacy stand point with clean tox then We can assume blue sky scenarios with 5B revs not there yet. price has to cool down a bit. IMO"
X Link 2025-12-06T00:48Z XXX followers, XXX engagements
"My prediction before JPM26: At least one more 15B acquisition $cytk - Sanofi $abvx - lilly $RVMD - Merck/Roche $BBIO -AZN $MDGL - NVO"
X Link 2025-12-03T19:37Z XXX followers, 19.6K engagements
"@seedy19tron Sanofi csl gsk azn and may be jnj use your imagination"
X Link 2025-12-05T23:24Z XXX followers, 1664 engagements
"@seedy19tron @AaronRosenblum5 Also $asnd is still cheap no competition is insight for yorvi multiple products with high rev growth could have been another insm but in wrong hands (management sucks)"
X Link 2025-12-06T00:55Z XXX followers, XXX engagements
"Sold this for a loss. would look to re-enter later"
X Link 2025-12-03T15:25Z XXX followers, XXX engagements
"@doepke_michel this could fit $cytk narrative too"
X Link 2025-12-03T19:19Z XXX followers, XXX engagements
"@aggregategains @doepke_michel why does it have to be a french comp"
X Link 2025-12-03T19:57Z XXX followers, XX engagements
"Contrarian trade idea: $janx XX puts are still cheap if the durability data disappoints stock would trade down by a lot these put could fly 3x-5x. There are lots of expectations going into XXX data ran almost XX% on the pre-data PR. If data is positive- you can buy $VIR stock after hours to minimize losses. NFA"
X Link 2025-12-01T17:10Z XXX followers, 4745 engagements
"Now that Evercore confirmed more 15B deals coming some more tickers for buyout predication $arwr - Gilead $asnd - Amgen"
X Link 2025-12-04T19:49Z XXX followers, 8129 engagements
"@Banana_Oncology Three names comes to mind Mrk - to fill in keytruda loe Roche- firepower to afford commercial giant in cancer therapies Azn - some synergies with ras ambition to become next decade onc power house Or may be a joint venture style acquisition.(long shot to mitigate risk)"
X Link 2025-12-06T05:09Z XXX followers, XXX engagements
"@Banana_Oncology Cant or a stretch to afford Not sure bod will signoff or will be confident to make such large acquisitions given not so great ROI from high profile acqs.25B is 1/4 th of the market cap.too much risk for them"
X Link 2025-12-06T05:23Z XXX followers, XXX engagements
"@seedy19tron @AaronRosenblum5 $rvmd is still affordable until it isn't soon"
X Link 2025-12-06T00:39Z XXX followers, XXX engagements
"If $abvx gets acquired soon then abbv will be more aggressively looking for combo therapies to protect their empire. $pali would be a good choice as it is gut restricted with no addt'l tox even $jnj needs this strategy even with or without $ptgx acquisition. they both need a small molecule (non-biologic) to combine. $pali is in a good spot either way"
X Link 2025-12-07T02:18Z XXX followers, 4621 engagements